Results 121 to 130 of about 5,794 (166)

A machine-learning algorithm using claims data to identify patients with homozygous familial hypercholesterolemia. [PDF]

Sci Rep
Gu J, Epland M, Ma X, Park J, Sanchez RJ, Li Y.   +5 more
europepmc   +1 more source

Lipoprotein apheresis: an established therapeutic modality for homozygous familial hypercholesterolemia patients refractory to PCSK9 inhibitors: a case report and literature review. [PDF]

Thromb J
Guan M, Wang H, Wang F, Liang S, Ling L, Wang B, Zhang L.   +6 more
europepmc   +1 more source

Homozygous Familial Hypercholesterolemia (le).

Indian journal of dermatology, venereology and leprology, 2012
P R, Somwanshi, N S, Agarwal
openaire   +1 more source

Sex Differences in Diagnosis, Treatment, and Cardiovascular Outcomes in Homozygous Familial Hypercholesterolemia.

JAMA Cardiol
Mulder JWCM, Tromp TR, Al-Khnifsawi M, Blom DJ, Chlebus K, Cuchel M, D'Erasmo L, Gallo A, Hovingh GK, Kim NT, Long J, Raal FJ, Schonck WAM, Soran H, Truong TH, Boersma E, Roeters van Lennep JE, Homozygous Familial Hypercholesterolemia International Clinical Collaborators.   +17 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Statins in homozygous familial hypercholesterolemia

Current Atherosclerosis Reports, 2002
Homozygous familial hypercholesterolemia is a rare disorder resulting in severe premature atherosclerosis. Drug therapy was previously viewed as inadequate for control of the dyslipidemia, so portacaval shunting, plasmapheresis, and liver transplantation were undertaken to treat this condition.
J C Firth, A D Marais
exaly   +3 more sources

Evinacumab for the treatment of homozygous familial hypercholesterolemia

Expert Review of Clinical Pharmacology, 2022
Hypercholesterolemia is mainly caused by abnormal lipoprotein metabolism and can increase the risk of cardiovascular disease. Angiopoietin-like protein 3 (ANGPTL3) can increase low-density lipoprotein cholesterol (LDL-C) and other lipids by inhibiting lipoprotein lipase activity.
Junyi Yang
exaly   +3 more sources

Homozygous Familial Hypercholesterolemia and Its Management

Seminars in Vascular Medicine, 2004
Mutations in the low-density lipoprotein (LDL) receptor gene cause familial hypercholesterolemia. In homozygous familial hypercholesterolemia, both genes for the LDL- receptor are mutated and LDL levels are markedly elevated. High-density lipoprotein cholesterol concentration is often reduced and lipoprotein(a) levels are high when corrected for ...
Adrian David, Marais, Jean Catherine, Firth, Dirk Jacobus, Blom   +2 more
exaly   +3 more sources

Homozygous familial hypercholesterolemia in Japan

The American Journal of Medicine, 1978
Abstract Fifty-one homozygous patients with familial hypercholesterolemia, including our six patients, are described in this paper. Twenty were men and 31 were women. Their ages ranged between two and 52 years, with a mean of 16.8 years. Six patients exceeded the third decade. The mean age at death in seven patients was 17 years. The serum cholesterol
H, Mabuchi, R, Tatami, T, Haba, K, Ueda, R, Ueda, T, Kametani, S, Itoh, J, Koizumi, M, Oota, S, Miyamoto, R, Takeda, H, Takeshita   +11 more
openaire   +2 more sources